-
Chinese scholars discovered gastric cancer anti-tumor immune "super soldier" cells
Time of Update: 2021-06-01
(Finish) Medical Network, May 27, after 3 years of research, Chinese medical experts have discovered and verified the "super soldier" against tumor cells in the gastric cancer microenvironment, providing a new model for the improvement of the prognosis prediction model of gastric cancer patients and the individualized choice of immunotherapy.
-
The incidence of colorectal cancer tends to be younger, and the starting age for screening has dropped to 45 years old
Time of Update: 2021-05-31
The USPSTF in the United States recommends reducing the starting age for colorectal cancer screening to 45 years old.
com/journals/jama/fullarticle/2779985?resultclick=1&appid=scweb&appid=scweb&alert=article The USPSTF in the United States recommends reducing the starting age for colorectal cancer screening to 45 years old.
-
New technology "Magnetic Knife" enters Chinese clinic to make Ford's tremor patients
Time of Update: 2021-05-31
The MRI-guided focused ultrasound brain system (Exablate Neuro) will be officially put into clinical use to treat drug-refractory essential tremor or tremor-based Parkinson's disease.
The MRI-guided focused ultrasound brain system (Exablate Neuro) will be officially put into clinical use to treat drug-refractory essential tremor or tremor-based Parkinson's disease.
-
Successfully cultivated human self-organized heart organoids that can beat autonomously
Time of Update: 2021-05-31
Scientists at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences have used human pluripotent stem cells to cultivate "mini" heart organoids, called "heart-like", which can organize themselves into a heart cavity-like structure without the need for an experimental scaffold, and can beat autonomously.
-
Will drinking milk regularly increase the risk of cardiometabolic diseases?
Time of Update: 2021-05-31
In this study, the researchers analyzed the data of 1,904,220 participants in three large-scale population studies (British Biobank, the 1958 British Birth Cohort Study, and the Health and Retirement Study of American Researchers) and found "T" and so on Alleles are significantly related to cardiovascular disease-related risk factors, such as higher BMI, lower levels of total cholesterol and low-density lipoprotein cholesterol (LDL-C, commonly known as bad cholesterol).
-
Prolong the "cancer-free survival" of early lung cancer immunotherapy can reduce the risk of recurrence
Time of Update: 2021-05-31
The results showed that compared with the best supportive therapy, atezolizumab in II-IIIA NSCLC patients with tumor PD-L1 expression> 1%, as an adjuvant therapy, reduced the patient’s risk of disease recurrence or death by 34% (HR=0.
-
New gene therapy successfully restores part of the visual function of blind people for the first time
Time of Update: 2021-05-31
Recently, the authoritative academic journal "Nature-Medical" published an exciting clinical trial result: a blind patient was diagnosed with retinitis pigmentosa 40 years ago.
Retrieved May 24, 2021 from for-first-time-to-help-blind-patient-see/Recently, the authoritative academic journal "Nature-Medical" published an exciting clinical trial result: a blind patient was diagnosed with retinitis pigmentosa 40 years ago.
-
Three innovative products including temporary pacemakers have been approved for listing
Time of Update: 2021-05-22
Three innovative products, "Paclitaxel-eluting PTCA Balloon Dilatation Catheter" and "Peripheral Nerve Sleeve" produced by Beijing Huifukang Medical Technology Co.
Three innovative products, "Paclitaxel-eluting PTCA Balloon Dilatation Catheter" and "Peripheral Nerve Sleeve" produced by Beijing Huifukang Medical Technology Co.
-
Chinese scientists have shown that "Qingfei Paidu Decoction" can effectively reduce the risk of death from new coronary pneumonia
Time of Update: 2021-05-21
A large-scale multi-center clinical study conducted by Professor Li Jing's team from Fuwai Hospital of the Chinese Academy of Medical Sciences showed that "Qingfei Paidu Decoction" can reduce the risk of death in hospitalized patients with new coronary pneumonia by half.
-
Review of Meropenem and Ambroxol Hydrochloride Injection for Shiyao Injection
Time of Update: 2021-05-20
The brand pattern of meropenem in China's public medical institutions in 2020 Source: Mi Nei. com, China's public medical institutions terminal competition pattern Ambroxol hydrochloride is a mucolytic agent developed by Boehringer Ingelheim.
-
4 billion contrast media, the sixth Beilu pharmaceutical company's iodixanol injection passed the consistency evaluation
Time of Update: 2021-05-20
cn/news/yyzb/" target="_blank"> The iodixanol injection was included in the fifth batch of centralized procurement, which will have an impact on the stock market of Hengrui Medicine's product.
-
Influenza innovative drug approved for listing in China brings convenient treatment options for patients
Time of Update: 2021-05-08
"(Finish) Medical Network, April 30, reporters learned on the 29th that the innovative flu drug Sufuda (Chinese common name: Mabaloxavir) was officially approved by the China National Medical Products Administration for the treatment of acute and uncomplicated cases of 12 years old and above.
-
my country's self-developed lung cancer targeted drugs show advantages in treating lung cancer brain metastases
Time of Update: 2021-04-27
In recent years, first-generation and second-generation drugs against EGFR targets associated with significantly improved advanced NSCLC without EGFR mutations in disease progression-free survival, but failed to bring significant change to this part of the overall survival of patients with advanced lung cancer, Moreover, patients receiving first-generation EGFR-TKI treatment are more likely to have brain metastases than patients receiving chemotherapy.
-
Chengdu Shengdi Pharmaceutical's Mycophenolate Sodium Enteric-coated Tablets to be imitated in Category 4 will be approved soon
Time of Update: 2021-04-27
Medical Network News on March 23 A few days ago, Chengdu Shengdi Pharmaceutical entered the administrative examination and approval stage with mycophenolate sodium enteric-coated tablets for imitation of category 4 applications.
-
Dual-antibody drugs are in the ascendant and are expected to become an important choice for clinical treatment in the future
Time of Update: 2021-04-22
Medical Network News April 21 Bispecific Antibodies (Bispecific Antibodies, BsAb) refers to antibodies that can bind two different antigens or different epitopes of an antigen at the same time, and can use its unique mode of action, such as connecting T cells and tumor cells , Synergistically inhibit signal pathways, form protein complexes, etc.
-
China's first fourth-line targeted drug for advanced gastrointestinal stromal tumors approved
Time of Update: 2021-04-18
This approval marks that Repetinib will become the first GIST fourth-line therapeutic drug approved to be marketed in Mainland China, filling the gap in the treatment of this disease in my country.
-
Eastern Sunshine Herbal Escitalopram Oxalate Tablets Entered the Administrative Approval Stage
Time of Update: 2021-03-30
Consistency evaluation and application status of escitalopram oxalate tablets (including new classification for production) Source: Meinenet MED2.
Consistency evaluation and application status of escitalopram oxalate tablets (including new classification for production) Source: Meinenet MED2.
-
Two injections of Sichuan Creed Pharmaceuticals continue to enter administrative approval
Time of Update: 2021-03-30
Recently, Sichuan Creed Pharma’s Sodium Valproate Injection and Micuronium Chloride Injection under the new registration classification have entered the administrative examination and approval stage.
Recently, Sichuan Creed Pharma’s Sodium Valproate Injection and Micuronium Chloride Injection under the new registration classification have entered the administrative examination and approval stage.
-
Chengdu Shengdi Pharmaceutical's Mycophenolate Sodium Enteric-coated Tablets to be imitated in Category 4 will be approved soon
Time of Update: 2021-03-27
Medical Network News on March 23 A few days ago, Chengdu Shengdi Pharmaceutical entered the administrative examination and approval stage with mycophenolate sodium enteric-coated tablets for imitation of category 4 applications.
-
my country's self-developed lung cancer targeted drugs show advantages in treating lung cancer brain metastases
Time of Update: 2021-03-26
In recent years, first-generation and second-generation drugs against EGFR targets associated with significantly improved advanced NSCLC without EGFR mutations in disease progression-free survival, but failed to bring significant change to this part of the overall survival of patients with advanced lung cancer, Moreover, patients receiving first-generation EGFR-TKI treatment are more likely to have brain metastases than patients receiving chemotherapy.
